Skip to main content
. 2018 Oct 23;5:180230. doi: 10.1038/sdata.2018.230

Figure 2. The workflow to identify and annotate the in vivo assay dataset.

Figure 2

(a) The in vivo assays within the ChEMBL database are identified. (b) The assays are annotated by reference animal models described by the Hock publications and/or by a disease or phenotypic endpoint with pharmacological or toxicological relevance. (c) The reference animal models or disease/phenotypic endpoints are mapped to MeSH terms.